CrossRefPubMed 12 Korkolopoulou P, Saetta AA, Levidou G, Gigelou

CrossRefPubMed 12. Korkolopoulou P, Saetta AA, Levidou G, Gigelou F, Lazaris A, Thymara I, Scliri M, Bousboukea K, Michalopoulos NV, Apostolikas N, Konstantinidou A, Tzivras M, Patsouris E: c-FLIP expression in colorectal carcinomas: association with Fas/FasL expression and prognostic implications. Histopathology 2007, 51: 150–6.CrossRefPubMed 13. Brummelkamp TR, Bernards R, Agami R: A system for stable expression of short interfering RNAs in mammalian cells. Science 2002, 296: 550–3.CrossRefPubMed

14. Flahaut M, Mühlethaler-Mottet A, Auderset K, Bourloud KB, Meier R, Popovic MB, Joseph JM, Gross N: Persistent inhibition of FLIP(L) expression by lentiviral small hairpin RNA delivery restores death-receptor-induced apoptosis in neuroblastoma cells. Apoptosis 2006, 11: 255–63.CrossRefPubMed selleck compound 15. Grigioni WF, D’Errico A, Bacci F, Gaudio M, Mazziotti A, Gozzetti G, Mancini AM: Primary liver neoplasms: evaluation of proliferative index using MoAb Ki-67. J Pathol 1989, 158: 23–9.CrossRefPubMed 16. Yang X, Khosravi-Far R, Chang HY, Baltimore D: Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell 1997, 89: 1067–76.CrossRefPubMed 17. Jäckel MC: Genetic PCI-32765 mw control of programmed cell death (apoptosis): prospects for biological tumor staging? HNO 1998, 46: 614–25.CrossRefPubMed 18. Okano H, Shiraki K, Inoue H, Kawakita T, Yamanaka T, Deguchi M, Sugimoto K, Sakai T, Ohmori S, Fujikawa K, Murata K, Nakano T: Cellular

FLICE/caspase-8-inhibitory EGFR inhibitor protein as a principal regulator of cell death and survival in human hepatocellular carcinoma. Lab Invest 2003, 83: 1033–43.CrossRefPubMed 19. Kataoka T, Budd RC, Holler N, Thome M, Martinon F, Irmler M, Burns K, Hahne M, Kennedy N, Kovacsovics M, Tschopp J: The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways. Curr Biol 2000, 10: 640–8.CrossRefPubMed 20. Kreuz S, Siegmund D, Scheurich P, Wajant H: NF-kappaB inducers upregulate cFLIP, a cycloheximide-sensitive

inhibitor of death receptor signaling. Mol Cell Biol 2001, 21: 3964–73.CrossRefPubMed 21. Lee SH, Kim HS, Kim SY, Lee YS, Park WS, Kim SH, Lee JY, Yoo NJ: Increased expression of FLIP, an inhibitor of Fas-mediated apoptosis, in stomach cancer. APMIS 2003, 111: 309–14.CrossRefPubMed 22. Thomas RK, Kallenborn A, Wickenhauser C, Schultze JL, Draube A, Vockerodt M, Re D, Diehl V, Wolf J: Constitutive expression of c-FLIP in Hodgkin and Reed-Sternberg cells. Am J Pathol 2002, 160: 1521–8.PubMed 23. Jönsson G, Paulie S, Grandien A: High level of c-FLIP correlates with resistance to death receptor-induced apoptosis in bladder carcinoma cells. Anticancer Res 2003, 23: 1213–8.PubMed 24. Korkolopoulou P, Goudopoulou A, Voutsinas G, Thomas-Tsagli E, Kapralos P, Patsouris E, Saetta AA: c-FLIP expression in bladder urothelial carcinomas: its role in resistance to Fas-mediated apoptosis and clinicopathologic correlations. Urology 2004, 63: 1198–204.CrossRefPubMed 25.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>